Search company, investor...
Syapse company logo


Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$35M | 4 mos ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+10 points in the past 30 days

About Syapse

Syapse develops applications that enable the use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. The Syapse Discovery application provides an end-to-end solution for companies and laboratories deploying sequencing-based diagnostics, from patient sample received to physician report delivered. Discovery's configurable semantic data structure enables users to bring omics data together with traditional medical information to develop and deliver diagnostic tests. The platform's open interfaces enable bioinformaticians and biologists to use their favorite computational tools and annotations. The company was formerly known as BDLicense. Syapse was founded in 2008 and is based in San Francisco, California.

Headquarters Location

303 2nd St., 5th Floor, Suite 500

San Francisco, California, 94107,

United States


ESPs containing Syapse

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Life Sciences / Biopharma Tech

Companies in this market offer alternative datasets that can supplement drug development, clinical trial execution, and clinical decision making. These companies collect data from a variety of sources, such has patient registries, EHRs, insurance databases, social media, and patient research networks.

Syapse named as Leader among 14 other companies, including Datavant, Aetion, and Evidation.

Compete with Syapse?

Ensure that your company and products are accurately represented on our platform.

Syapse's Products & Differentiators


    An open-ended, flexible interface for data scientists to leverage easy-to-adapt algorithms, and multiple data sources, to tailor their analysis

Expert Collections containing Syapse

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Syapse is included in 9 Expert Collections, including Digital Health.


Digital Health

21,956 items

Startups recreating how healthcare is delivered


Clinical Trials Tech

364 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.


Artificial Intelligence

9,442 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Digital Health 150

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry


Value-Based Care & Population Health

1,060 items

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Latest Syapse News

Precision Medicine Software Market Regional Analysis, Industry Growth, Profits 2028 | Syapse, 2bPrecise, Gene42,

Oct 31, 2022

| Syapse, 2bPrecise, Gene42, News Provided By Share This Article Precision Medicine Software Market Precision medicine software is an emerging approach for the prevention and treatment of diseases such as cancer, rare illness, and infectious diseases. SEATTLE, WASHINGTON, UNITED STATES, October 31, 2022 / / -- The exclusive research report on ' Precision Medicine Software Market ' now available with ???????????????????????????????? ???????????????????????? ????????????????????????????????, offers a detailed analysis of the factors influencing the global business sphere. This report also provides precise information pertaining to market size, commercialization aspects and revenue estimation of this business. The report further elucidates the status of leading industry players thriving in the competitive spectrum of the Precision Medicine Software Market. The research report incorporates a detailed evaluation of this industry and a commendable brief of its segments. The study is inclusive of a basic overview of this market with respect to the current industry status and the market size, on the basis of volume and revenue. The study offers a synopsis of significant details such as the regional landscape of the industry as well as the firms that have established a strong position in the market. Click Here for Sample Copy (Use corporate email ID Get Higher Priority) @ Term Market's Range: new patterns, The study on the keyword market paints a thorough picture of present/future prospects and demands that are advantageous to both individuals and market participants. Based on the major market dynamics as well as the growth-improving factors, this study calculates the market value and growth rate. The most recent market trends, industry news, and growth probabilities serve as the foundation for the entire study. Along with a SWOT analysis of the well-known competitors, it also includes a thorough analysis of the market and competitive environment. ???? ???????????????????????????????? ???????? ???????????? ???????????????????????????????? ???????????????????????????????????? ???????? ???????????? ????????????????????????: • The research report broadly enumerates the regional terrain of this industry. As per the study, Precision Medicine Software Market regional landscape is bifurcated into ???????????????????? ????????????????????????????, ????????????????????????, ???????????????? ????????????????????????????, ???????????????????? ????????????????????????????, ???????????????????????? ????????????????, ????????????????????????. • The study delivers substantial information pertaining to the market share that every region is estimated to hold, in tandem with the growth opportunities projected for each geography. • The report depicts the growth rate in which every topography is estimated to register over the forecast time period. ???????? ???????????????????????????? ???????? ???????????? ???????????????????????????????????????????? ???????????????????????????????????? ???????? ???????????? ????????????????????????: • The comprehensive market report is inclusive of a detailed summary of the competitive analysis of this industry. As per the document, companies along the likes of Syapse, Inc., 2bPrecise LLC, Foundation Medicine, Inc., Fabric Genomics, SOPHiA GENETICS SA, Gene42, Inc., LifeOmic Health, LLC, NantHealth, Inc., and Koninklijke Philips N.V. are encompassed in the competitive spectrum of the market. • Data related production sites, market share, area served, and more have been covered in the report. • The report elucidates data pertaining to the manufacturer’s product portfolio, product specifications, as well as numerous product applications. • A brief outline of the firm in question, its profit margins and pricing models are explained in the report as well. For More Information or Query or Customization before Buying, Visit at – The study assists in giving a more thorough introduction to the market as well as in dealing with the intricate research technique used to determine the market's size and projections. For the purpose of validating data, secondary data sources are used along with primary inputs. This section also aids in highlighting the many topics that have been included in the report. Additionally, assessments frequently include calculations for figuring out the tendencies of the global industry. ???????????????? ???????? ???????????? ???????????????????? ???????????????????????????????????????? ???????? ???????????? ????????????????????????: ???????????????????????????????? ???????????????????????? ???????????????????????????????? - • Global Consumption by Application ???????????????????? ???????????????????????????????????????????????????? ???????????????????????????????? - • Product Introduction, Application, and Specification • Production, Revenue, Ex-factory Price and Gross Margin • Main Business and Markets Served Up-To Avail 30% Discount on various license types on immediate purchase @ About US: Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients. Mr. Shah +1 206-701-6702

Syapse Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Syapse Rank

Syapse Frequently Asked Questions (FAQ)

  • When was Syapse founded?

    Syapse was founded in 2008.

  • Where is Syapse's headquarters?

    Syapse's headquarters is located at 303 2nd St., 5th Floor, Suite 500, San Francisco.

  • What is Syapse's latest funding round?

    Syapse's latest funding round is Unattributed VC.

  • How much did Syapse raise?

    Syapse raised a total of $204.5M.

  • Who are the investors of Syapse?

    Investors of Syapse include Social Capital, Safeguard Scientifics, Merck Global Health Innovation Fund, Revelation Partners, Ally Bridge Group and 13 more.

  • Who are Syapse's competitors?

    Competitors of Syapse include Validic, COTA, Tempus, Clearsense, Upfront Healthcare,, Abacus Insights, Owkin, Lumiata, Clareto and 37 more.

  • What products does Syapse offer?

    Syapse's products include Sandbox and 2 more.

  • Who are Syapse's customers?

    Customers of Syapse include Pfizer, Amgen and Henry Ford Health System.

Compare Syapse to Competitors

Aetion Logo

Aetion delivers real-world evidence for life sciences companies, payers, at-risk providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce rapid and scientifically validated answers on treatments, costs, and outcomes. Aetion informs health care's most critical decisions - what works best, for whom, and when - to guide treatment development, commercialization, and payment values into health care's modern era.

Evidation Logo

Evidation measures health in everyday life and enables anyone to participate in research and health programs. Evidation is a two-sided platform that connects individuals and enterprises. On the consumer side, the company assists individuals to participate in research including testing of digital health programs. On the enterprise side, Evidation provides biopharma, med-tech, big tech, academic institutions, professional societies, and government partners the ability to: generate evidence; and design, test, and deploy programs that motivate evidence-based action.


OM1 develops a data analytics platform to predict the outcomes of patients so that hospitals, healthcare systems, and other stakeholders can make better decisions about how to care for those patients. The company serves the healthcare industry. It was founded in 2015 and is based in Boston, Massachusetts.

HealthVerity Logo

HealthVerity provides technologies and software tools for the discovery and integration of optimal patient data sets. The company works with pharmaceuticals, hospitals, and payer customers to maximize the insights from data supplier relationships.

Ferrum Health

Ferrum Health runs quality assurance algorithms on patient data generated across health systems to detect opportunities to close gaps across the continuum of care. Logo is an artificial intelligence-based precision health platform that allows users to integrate data from a variety of disparate sources, create AI models to predict health outcomes and support clinical decisions optimized for individual patients, and monitor and aggregate the impact of interventions over time to make decisions for the patients. The company was formerly known as Deep Health Technologies, Inc. and changed its name to Inc. in 2018. It provides various predictive models that include unplanned hospital admissions, preventable hospitalization, chronic kidney, diseases, and more. The company was founded in 2017 and is based in Austin, Texas.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.